|
|
|
|
|
|
Scientific Advisory Boards
Cardax Pharmaceuticals has put together two world-class and interactive Scientific Advisory Boards with members in several relevant areas, including:
BREAKING NEWS:
The American Journal of Cardiology publishes: "Oxidative Stress and Heart Disease", a journal supplement based on presentations from the first Cardax Cardiovascular Scientific Advisory Board meeting.
Am J Cardiol 2008; 101 (10, Suppl 1)
Cardiovascular SAB - Cardiovascular Medicine
|
Deepak Bhatt, M.D., SAB Chairman.
Chief of Cardiology at the VA Boston Healthcare System and Director of the Integrated Interventional Cardiovascular Program at Brigham and Women's Hospital and the VA Boston Healthcare System. International Principal Investigator for the CHARISMA trial and several other major cardiovascular trials.
|
|
|
Charles L. Campbell, M.D.
Assistant Professor of Medicine and Director of the Cardiac Intensive Care Unit at the University of
Kentucky. His research explores new therapies for treating acute coronary syndrome, oxidative stress
and cardiogenic shock.
|
|
|
Steven R. Steinhubl, M.D.
Director of Cardiovascular Research and Education, Cardiology
Fellowship Program Director, Staff Interventional Cardiologist and Associate Professor of
Medicine at the University of Kentucky. Principal Investigator of both STEEPLE and ACUITY
trial and Co-Chairman of CREDO. Executive Committee of several large, multi-center RCT’s including
CHARISMA, SYNERGY, FREEDOM, STRADIVARIUS, SHINE, PROSPECT, and CRESCENDO.
|
|
|
|
|
|
